Brea-Krüger, Mariana (IMI Consulting 200503 Managing Director) |
Managing Director |
IMI Consulting GmbH |
Germany |
Brecht, René (ProBioGen 2002– VP Process Science + Manufacturing before Univ Leipzig) |
n. a. |
Minapharm (Group) |
Germany |
Brégand, Eric (TEMIS 200809 CEO) |
Chief Executive Officer (CEO) |
Expert System (Group) |
France |
Breidbach, Andreas (EU (govt) 200609– EC-JRC-IRMM) |
Researcher (university / research institute) |
EU (govt) |
Belgium |
Breimesser, F. H. |
n. a. |
Siemens (Group) |
Germany |
Breiner, Klaus (BB Biotech Ventures + Vaximm 201605 Executive Chairman) |
Board member, executive |
Vaximm (Group) |
Switzerland |
Breitenstein, Urs (Nemis Technologies 202202 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
Nemis Technologies AG |
Switzerland |
Bremer, Ralf (Gerstel 201402 Managing Director, RnD + Production) |
Managing Director |
Gerstel (Group) |
Germany |
Bremus, Christoph (Phenospex 201909– Chief Commercial Officer before Eppendorf + DASGIP) |
n. a. |
OTHER |
|
Brenker, Kathrin (Opto Biolabs 201906– Managing Director + Founder) |
Managing Director |
Opto BIolabs GmbH (formerly UG) |
Germany |
Brennan, John (EuropaBio –201808 Secretary General LEFT 9/18) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
Brennecke, Marcus (EQT Partners 201706 Partner + Investment Advisor to EQT VII fund) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
|
Brennecke, Thomas (Staatz Business Development & Strategy) |
consulting (economic) |
Staatz Business Development & Strategy – Dr. Irina Staatz-Granzer |
Germany |
Brenning, Thomas |
n. a. |
Helaba (Group) |
Germany |
Bresch, Heather (Mylan 201310 CEO) |
Chief Executive Officer (CEO) |
Viatris (Group) |
United States (USA) |
Bressi, Jeanette (MorphoSys 202012 Director US Communications) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
United States (USA) |
Brett, Catherine (Innovative Medicines Initiative 201807 External Relations Manager) |
President/Director/Head Business Group/Unit/Division |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
Brett, Gerard (Vivasure Medical 201609 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Vivasure Medical Ltd. |
Ireland, Republic of |
Breu, Jessica (Immunic 201904 Manager IR + Communications) |
Public Relations Manager / Investor Relations Manager |
Immunic (Group) |
Germany |
Breu, Raymund (Novartis –2001003 CFO retires 3/10) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
Breuer, Sebastian (Genetics Company 200608 Program Manager Diagnostics) |
Product Manager (personnel) |
Genetics Company Inc., The |
Switzerland |
Breugelmans, Matthias (Elastrin 202209 CEO) |
Chief Executive Officer (CEO) |
Elastrin Therapeutics |
|
Breuker, Kathrin (Univ Innsbruck 201005 Principal Investigator Institute of Organic Chemistry) |
Researcher (university / research institute) |
University of Innsbruck |
Austria |
Brewis, Neil (F-Star 201611 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sino Biopharm (Group) |
United Kingdom (GB) |
Brichard, Vincent (Life Sciences Partners 2016– Venture Partner before GSK SVP + Head of Immunotherapeutics) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Netherlands |
Brickwedde, Fritz (DBU 200501) |
n. a. |
Deutsche Bundesstiftung Umwelt DBU |
Germany |
Briel, Andreas (NanoPET Pharma GmbH 201412 Managing Director) |
Managing Director |
NanoPET Pharma GmbH |
Germany |
Brilling, Julia (Norgenta 201211 Project Manager Industrial Cell Technology) |
Cluster Manager |
Hamburg (govt region) |
Germany |
Brinke-Seiferth, Stephan (i3 Membrane GmbH 201306– Managing Director + Founder) |
Managing Director |
i3 membrane GmbH |
Germany |
Brinkhaus, Franck (Biotech Alliances International Inc 201810 CEO before Woodside Capital Partners) |
Chief Executive Officer (CEO) |
Biotech Alliances International Inc. |
United States (USA) |
Brinkhoff, Günter |
n. a. |
BioAgency AG |
Germany |
Brinkmann, Klaus (Curetis 201112– Director of Sales before Bio-Rad (DE) + Becton Dickinson GmbH + Beckman Coulter GmbH) |
Sales Manager / Marketing Manager |
OpGen (Group) |
Germany |
Brinkmann, Maximilian (Max) (Refined Laser Systems 202301 Managing Director + Co-Founder) |
Managing Director |
Refined Laser Systems GmbH |
Germany |
Brinkmann, Thomas (Unilabs 201306 CMO) |
Chief Medical Officer (CMO) |
Unilabs (Group) |
Denmark |
Brinzey, Christopher F. (Chris) (Westwicke Partners 201703) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United States (USA) |
Brister, David (Evotec 200609– before MVM Ltd before 3i before Metal Box plc) |
n. a. |
Evotec (Group) |
Germany |
Britten, Cedrik (Immatics 202006– CMO before GSK VP + Head of Oncology Cell Therapy Research Unit + BioNTech) |
Chief Medical Officer (CMO) |
Immatics (Group) |
Germany |
Brix, Klaudia (Jacobs Univ Bremen 201104 Professor of Cell Biology) |
Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
Brkulj, Mario (MacDougall 201511 VP before MorphoSys + Biocom) |
Public Relations Manager / Investor Relations Manager |
MacDougall Biomedical Communications Inc. (MBI) |
Germany |
Brock, Stephan (Molecular Health 201401 CEO of European division before Metalife + LION Bioscience) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
Germany |
Brockhoff, Gero (Univ Regensburg 2006 Institute for Pathology) |
Researcher (university / research institute) |
University of Regensburg, Institute for Pathology (IPUR) |
Germany |
Brockmeyer, Carsten (Formycon 201305 CEO) |
Chief Executive Officer (CEO) |
Formycon (Group) |
Germany |
Brodard, Lionel (MedXCell 202106 CFO) |
Chief Financial Officer (CFO) |
MedXCell (Group) |
Switzerland |
Brodbeck, Sonja (co:bios Technologiezentrum 201104 Managing Director) |
Managing Director |
co:bios Technologiezentrum GmbH |
Germany |
Brodkorb, Mathias (Mecklenburg-Vorpommern (govt) 201312 Minister for Education + Science) |
Minister |
Mecklenburg-Vorpommern (govt region) |
Germany |
Broer, Wim (Cotecna 201712 Manager Developm + Science at NofaLab) |
n. a. |
Cotecna (Group) |
Netherlands |
Broja, Christoph (EQT 202306 Managing Director at EQT Life Sciences) |
Managing Director |
EQT (Wallenberg family) (Group) |
Netherlands |
Brons, Tim (Vida Strategic Partners 201907) |
Public Relations Manager / Investor Relations Manager |
Vida Strategic Partners |
United States (USA) |
Bronsema, Viola (BIO Deutschland 200905 Managing Director + CureVac 202008– Supervisory Board Member) |
Managing Director |
BIO Deutschland e. V. |
Germany |
Bronstein, Michael (Austrian Academy of Sciences 202409– Founding Director of AITHYRA Institute before Univ Oxford) |
President/Director/Head of Research Organisation/Unit |
Austrian Academy of Sciences (Österreichische Akademie der Wissenschaften, ÖAW) |
Austria |
Brooke, Paul (venBio 201204 Partner before Morgan Stanley) |
Partner (venture partner) |
VenBio (Group) |
United States (USA) |
Broom, Colin (Nabriva 201409– CEO before ViroPharma CSO) |
Chief Executive Officer (CEO) |
Nabriva (Group) |
Austria |
Brosch, Markus (Genedata 201905 Business Unit Head for Genedata Expressionist) |
Product Manager (personnel) |
Danaher (Group) |
Switzerland |
Brosnan, Michael (Fresenius Medical Care 201804 CFO + proposed to MorphoSys Supervisory Board) |
Chief Financial Officer (CFO) |
Fresenius (Group) |
Germany |
Brossmer, Reinhard (SialoTec GmbH 201601– Managing Director) |
Managing Director |
SialoTec GmbH |
Germany |
Brouillon, Carinne (Boehringer Ingelheim –202410 Managing Director for Human Pharma Business RETIRED 10/24) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Brown, Colin (Roche 201112 Head of Roche Professional Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Brown, Gregory B. (Cowen 201206 Managing Director of Cowen Royalty) |
Managing Director |
TD Bank (Group) |
United States (USA) |
Brown, Paul (Roche 201103 Head Roche Molecular Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Brown, Shaun (MC Services 201603) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Brown, Stephanie (Santhera 202112– President North America + Executive Board Member before Ipsen US + Novartis US) |
Board member, executive |
Santhera (Group) |
United States (USA) |
Browning, Rod (Xradia 201306 CEO) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
United States (USA) |
Broyer, Mark (AllyWell 202412 Managing Director) |
Managing Director |
AllyWell GmbH (AllyTime) |
Germany |
Bruce, Michael (Exo Therapeutics 202012 CEO) |
Chief Executive Officer (CEO) |
Exo Therapeutics Inc. |
United States (USA) |
Bruch, Jens (Italy (govt) 201603 ICE German Office) |
Administrative Officer (personnel) |
Italy (govt) |
Germany |
Bruchmann, Andreas (Axel Semrau 202111 Managing Director) |
Managing Director |
Trajan (Group) |
Germany |
Bruchmann, Dietrich (Nuvisan 2022 Managing Director of Nuvisan Pharma Holding GmbH) |
Managing Director |
Nuvisan (Group) |
Germany |
Bruchmann, Friderike (XO Life 202202 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
XO Life GmbH |
Germany |
Bruderer, Roland M. (Biognosys 201601 Senior Scientist Mass Spectrometry) |
mass spectrometry (MS) |
Bruker (Group) |
Switzerland |
Brudnick, Richard (Codiak BioSciences 201902 CBO + Head of Strategy before Bioverativ + Biogen + Bain & Co) |
Business Development Manager / Strategy Manager |
Codiak BioSciences Inc. |
United States (USA) |
Bruellhoff, Kristina (PS Biotech GmbH 201305 Managing Director + Co-Founder) |
Managing Director |
PS Biotech GmbH |
Germany |
Bruhn, Heiko (Mediatum 201209 Managing Director of Mediatum Schweiz GmbH) |
Managing Director |
Mediatum (Group) |
Switzerland |
Bruinsma, Gosse B. (IDEA 201002– CEO before Axonyx 200606 CEO) |
Chief Executive Officer (CEO) |
IDEA AG |
Germany |
Brumm, Joshua (Josh) (Forbion 202406– General Partner before Dyne Tx + Kaleido Biosciences + Versartis + Pharmacyclics) |
Chief Executive Officer (CEO) |
Forbion (Group) |
Netherlands |
Brummelkamp, Thijn (Haplogen 2010– Founder) |
Company Founder |
Haplogen Bioscience GmbH |
Austria |
Brun, Virginie (PX'Therapeutics 201008– CSO + co-founder of Promise Advanced Proteomics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Aguettant (Group) |
France |
Bruncko, Martin (EU (govt) 202201 Member of EIC Fund Investment Committee) |
Investment Manager |
EU (govt) |
EU (European Union) |
Brunel, David (Biodesix 200810 CEO) |
Chief Executive Officer (CEO) |
Biodesix Inc. |
United States (USA) |
Brunken, Heiko (Hochschule Bremen 201303 Professor for Ecology + Environmental Protection) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
Brunner, Eduard M. (Creoptix 201909 Board Chairman) |
Board member, non-executive |
Spectris (Group) |
Switzerland |
Brunner, H. |
n. a. |
Fraunhofer (Group) |
Germany |
Brunner, Thomas (BioTek Instruments GmbH 200704 CEO) |
Chief Executive Officer (CEO) |
Agilent (Group) |
Germany |
Brunnhuber, Barbara (Mireca Medicines 202204 CEO) |
Chief Executive Officer (CEO) |
Mireca Medicines GmbH |
Germany |
Bruno, Michael (Crosshair Therapeutics 202201 CEO + Founder) |
Chief Executive Officer (CEO) |
Crosshair Therapeutics Inc. |
United States (USA) |
Bruno-Raimondi, Alfredo E. (Freibiotics 201012 Managing Director) |
Managing Director |
Freibiotics GmbH |
Germany |
Bruns, Ingmar (Pieris 201710– VP Clinical Development before Bayer Pharmaceutical since 2013) |
Clinical Research Manager |
Palvella Therapeutics (Group) |
United States (USA) |
Bruns, Olaf (Kompass Private Equity 200710– Managing Director before 3i Group before Arthur Andersen) |
Managing Director |
Kompass (Group) |
Germany |
Bruns, Stefan (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
Brunswiek, Soenke (PharmCell 201501 Director Business Development) |
Business Development Manager / Strategy Manager |
Lonza (Group) |
Netherlands |
Brusdeilins, Martin (Tecan 201109–201409 RETIRED 9/14 before Ortho-Clinical Diagnostics + Roche Diagnostics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Tecan (Group) |
Switzerland |
Bruss, Marina (BioTek Instruments GmbH 200809) |
Sales Manager / Marketing Manager |
Agilent (Group) |
Germany |
Brutsche, Florian (UbiSim 202110 Co-Founder) |
Company Founder |
Labster (Group) |
Switzerland |
Brübach, Amélie (Messe Stuttgart 201807 Head Communications Industry + Technology) |
public relations / investor relations |
Messe Stuttgart (Landesmesse Stuttgart GmbH) |
Germany |
Brücher, Christoph |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
Brück, Thomas (TU Munich 201604 Prof of Industrial Biocatalysis) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
Brück, Wolfgang (Univ Göttingen 202302 Executive Board Member at Univ Medical Center formerly Charité) |
President/Director/Head of Research Organisation/Unit |
University of Göttingen (Georg August University) |
Germany |
Brügemann, Lutz (Bruker 200905 Director RnD + Marketing) |
n. a. |
Bruker (Group) |
United States (USA) |
Brüggemann, Andrea (Nanion Technologies GmbH 201102 Managing Director CSO) |
Managing Director |
Nanion (Group) |
Germany |
Brüggen, Jochen |
n. a. |
PERSON |
|
Brühlmann, Christian (Proteomedix 202001 COO/CFO) |
Chief Operating Officer (COO) |
Proteomedix AG |
Switzerland |